The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells
Abstract
Tumor cells fuel their metabolism with glucose and glutamine to meet the bioenergetic and biosynthetic demands of proliferation. Hypoxia and oncogenic mutations drive glycolysis, with the pyruvate to lactate conversion being promoted by increased expression of lactate dehydrogenase A and inactivation of pyruvate dehydrogenase. The NAD+ pool is consecutively regenerated and supports the high glycolytic flux required to produce anabolic intermediates. Glutaminolysis provides metabolic intermediates such as alpha-ketoglutarate to feed and thereby maintain the tricarboxylic acid cycle as a biosynthetic hub. Glycolysis and glutaminolysis share the capacity to generate NADPH, from the pentose phosphate pathway and through the malate conversion into pyruvate, respectively. Both pathways ultimately lead to the secretion of lactate. More than a waste product, lactate was recently identified as a major energy fuel in tumors. Lactate produced by hypoxic tumor cells may indeed diffuse and be taken up by oxygenated tumor cells. Preferential utilization of lactate for oxidative metabolism spares glucose which may in turn reach hypoxic tumor cells. Monocarboxylate transporter 1 regulates the entry of lactate into oxidative tumor cells. Its inhibition favors the switch from lactate-fuelled respiration to glycolysis and consecutively kills hypoxic tumor cells from glucose starvation. Combination with radiotherapy renders remaining cells more sensitive to irradiation, emphasizing how interference with tumor cell metabolism may complement current anticancer modalities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pyruvate is converted to acetyl-CoA through mitochondrial pyruvate dehydrogenase (PDH), whereas acetate is transported into cells and converted to acetyl-CoA through acetyl-CoA synthase (De Schrijver et al., 2003; Feron, 2009; Koukourakis et al., 2005; Pizer et al., 1996; Yoshimoto et al., 2001; Zaidi et al., 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Feron, 2009
In the citing paper
“pyruvate or acetate can act as an alternative source to glucose and glutamine for lipid biosynthesis.”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Feron, 2009
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 561
Tarhini, A. A. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.08.012 · Cited by 7
Molecular cloning and characterization of lactate dehydrogenase gene 1 in the silkworm, Bombyx mori
Xia, H., Wu, C., Xu, Q., Shi, J., Feng, F., Chen, K., Yao, Q., Wang, Y., & Wang, L. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0302-0 · Cited by 7
Lee, J.-H., Son, S., Ko, Y., Lim, H., Lee, M., Kang, M.-G., Kim, H., Lee, K., & Shin, I. (2025) · Scientific Reports · doi:10.1038/s41598-024-84880-5 · Cited by 9
The Role of Lactate Metabolism in Tumors
Tian, Z., Zhang, K., Sheng, S., Kan, C., Han, F., & Sun, X. (2025) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000001276 · Cited by 7
Qiu, D., He, Y., Feng, Y., Lin, H.-T., Lin, Z., Zhang, Z., Xiong, Y., Hu, Z., Ma, S., Jin, H., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1424824 · Cited by 6
An “off-on” fluorescent probe for imaging pyruvic acid in living systems
Li, M., Li, X., Chen, L., Li, X., & Liu, C. (2024) · Talanta · doi:10.1016/j.talanta.2024.127225 · Cited by 5
L-serine promotes pro-carcinogenic effects of colibactin-producing E. coli
Devaux, A., Villéger, R., Roche, G., Diémé, B., Rodrigues, M., Juban, C., Lagrée, M., Venisse, N., Jousse, C., Barnich, N., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2515480 · Cited by 7
Shin, S., Kwon, Y., Ye, D.-J., Baek, H., Kwon, T.-U., Kim, D., & Chun, Y. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.005 · Cited by 6
Watanabe, M., Sheriff, S., Kadeer, N., Cho, J., Lewis, K. B., Balasubramaniam, A., & Kennedy, M. A. (2011) · Metabolomics · doi:10.1007/s11306-011-0380-6 · Cited by 6
Delineating cell behavior and metabolism of non-melanoma skin cancer in vitro
Mendez, T., Saffari, S., Cowan, J. M., Laver, N., Baleja, J., & Alt‐Holland, A. (2020) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-019-00416-6 · Cited by 6
Dierolf, J. G., Watson, A. J., & Betts, D. H. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112714 · Cited by 7
Mathematical Modeling of Retinal Degeneration: Aerobic Glycolysis in a Single Cone
Camacho, E. T., Dobréva, A., Larripa, K., Rǎdulescu, A., Schmidt, D. R., & Trejo, I. (2020) · Association for Women in Mathematics series · doi:10.1007/978-3-030-57129-0_7 · Cited by 6
Abdelrahman, R. E., Hassan, M. S., Morgan, A. M., Ibrahim, M. A., & Hassanen, E. I. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70321 · Cited by 5
Potential biomarkers in early detection of gastric cancer
Kaur, S., Kumar, A., Bhatia, R., Choudhary, D., Kaur, R., Chandrasekaran, B., Dayyih, W. A., Maaita, M. N., & Hourani, W. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1642927 · Cited by 5
Ranawat, P., Kaur, N., & Koul, A. (2023) · Scientific Reports · doi:10.1038/s41598-022-26152-8 · Cited by 5
Hamed, M. A., Akhigbe, R. E., Ekundina, V. O., & Oluwole, D. T. (2025) · Comparative Clinical Pathology · doi:10.1007/s00580-025-03647-0 · Cited by 5
Bansal, N., Alaseem, A. M., Babu, A. M., Alasiri, G. A., Singh, T. G., Tyagi, Y., & Sharma, G. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11362-9 · Cited by 5
A new approach to biological modeling: Introduction to the biology of functions
Hedayat, K. M., & Lapraz, J.-C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816903-2.00015-x · Cited by 5
Lactate Dehydrogenase in Hypertensive Disorders in Pregnancy: Severity or Diagnosis Marker?
Vázquez-Alaníz, F., Salas-Pacheco, J. M., Sandoval-Carrillo, A. A., Llave-León, O. L., Hernández, E., Barraza-Salas, M., Ramírez‐Valles, E. G., Úrtiz-Estrada, N., Lumbreras-Marquez, M. I., Montes-Herrera, J. M., et al. (2019) · Journal of Hypertension and Management · doi:10.23937/2474-3690/1510040 · Cited by 5
Zhu, Q., Zeng, S., Yang, J., Zhuo, J., Wang, P., Wen, S., & Fang, C. (2024) · Nanoscale · doi:10.1039/d4nr01587h · Cited by 5
Liu, C., Yan, S., Luo, X., Zheng, Y., & Zhen, G. (2025) · Water Research · doi:10.1016/j.watres.2025.123677 · Cited by 5
Schobert, I. T., Chapiro, J., Pucar, D., Saperstein, L. A., & Savic, L. J. (2019) · PET Clinics · doi:10.1016/j.cpet.2019.06.008 · Cited by 5
Silvano, A., Menegazzi, G., Peppicelli, S., Mancini, C., Biagioni, A., Tubita, A., Tusa, I., Ruzzolini, J., Lulli, M., Rovida, E., et al. (2022) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504022x16442289212164 · Cited by 5
Li, D., Chen, S., Liu, C., Wei, B., & Li, X. (2022) · Inhalation Toxicology · doi:10.1080/08958378.2022.2083275 · Cited by 5
Pazopanib-Induced Hepatotoxicity in an Experimental Rat Model
Çetin, B., Yılmaz, G., Armağan, B., Afşar, B., Demırcı, U., Gülbahar, Ö., Gümüşay, Ö., Bilgetekin, İ., Özet, A., & Üner, A. (2018) · Chemotherapy · doi:10.1159/000481795 · Cited by 5
Jenniskens, J. C. A., Offermans, K., Simons, C. C. J. M., Samarska, I. V., Fazzi, G. E., van der Meer, J. R. M., Smits, K. M., Schouten, L. J., Weijenberg, M. P., Grabsch, H. I., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04019-9 · Cited by 5
Feasibility of multianimal hyperpolarized 13 C MRS
Ramirez, M. S., Lee, J., Walker, C. M., Chen, Y., Kingsley, C. V., de la Cerda, J., Maldonado, K. L., Lai, S. Y., & Bankson, J. A. (2014) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25307 · Cited by 5
Cancer Development and Progression and the “Hallmarks of Cancer”
Mazingi, D., & Lakhoo, K. (2025) · Springer eBooks · doi:10.1007/978-3-031-76882-8_23 · Cited by 6
Ponton-Almodovar, A. L., Udumula, M. P., Khullar, V., Rashid, F., Rattan, R., Bernard, J. J., & Horibata, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-15707-0 · Cited by 4
Kluz, N., Kraj, L., Chmiel, P., Przybyłkowski, A. M., Wyrwicz, L. S., Stec, R., & Szymański, Ł. (2024) · Cancers · doi:10.3390/cancers16233945 · Cited by 5
Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma
Fujiwara, M., Mimae, T., Kushitani, K., Tsubokawa, N., Miyata, Y., Takeshima, Y., & Okada, M. (2024) · Anticancer Research · doi:10.21873/anticanres.17352 · Cited by 4
Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2
Xu, B., Zhou, X., Shan, Y., Shi, S., Li, J., Liang, Q., Wang, Z., Zhang, M., Wang, Y., Pei, D., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00661-9 · Cited by 4
Cancer Development and Progression and the “Hallmarks of Cancer”
Mazingi, D., & Lakhoo, K. (2023) · Springer eBooks · doi:10.1007/978-3-030-71113-9_23-1 · Cited by 4
Kośnik, W., Sikorska, H. M., Kiciak, A., & Ciach, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010645 · Cited by 4
Hou, S., Zhang, L., Ji, H., Zhao, T., Hu, M., Jiang, Y., Sun, Q., Zhang, M., & Dou, M. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04110-8 · Cited by 4
Glutamate Signaling in Human Cancers
Brian, A., Shin, S., & Che, S. (2013) · InTech eBooks · doi:10.5772/55174 · Cited by 4
Molecular basis for the regulation of hypoxia-inducible factor-1α levels by 2-deoxy-D-ribose
Ikeda, R., Tabata, S., Tajitsu, Y., Nishizawa, Y., MINAMI, K., Furukawa, T., Yamamoto, M., Shinsato, Y., Akiyama, S., Yamada, K., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2572 · Cited by 4
Pseudohypoxia, Mitochondrial Mutations, the Warburg Effect, and Cancer.
Sanders, E. (2012) · Cited by 4
Gilloteaux, J., Bhalla, A., Faour, O., & Jamison, J. M. (2016) · Ultrastructural Pathology · doi:10.3109/01913123.2016.1155684 · Cited by 4
Gašperšič, J., Kastelic, M., Novak, U., & Likozar, B. (2018) · Acta chimica slovenica · doi:10.17344/acsi.2018.4591 · Cited by 5
Mitophagy and Reverse Warburg Effect: Metabolic Compartmentalization of Tumor Microenvironment
Naik, P. P. (2020) · Springer eBooks · doi:10.1007/978-981-15-6930-2_6 · Cited by 4
Ren, X., Liu, M., Tang, M., Tan, L., Fu, C., Wu, Q., Li, H., Chen, Y., Chen, L., & Meng, X. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3158 · Cited by 4
Jenniskens, J. C. A., Offermans, K., Simons, C. C. J. M., Samarska, I. V., Fazzi, G. E., van der Meer, J. R. M., Smits, K. M., Schouten, L. J., Weijenberg, M. P., Grabsch, H. I., et al. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23459 · Cited by 4
Alosaimi, M. E., Alotaibi, B. S., Abduljabbar, M. H., Alnemari, R. M., Almalki, A. H., & Serag, A. (2024) · Journal of Chromatography B · doi:10.1016/j.jchromb.2024.124144 · Cited by 4
Organic nanocarriers for targeted delivery of anticancer agents
Dahiya, S., & Dahiya, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00010-9 · Cited by 4
Diagnosis of Stage IV Melanoma
Tarhini, A. A., Agarwala, S. S., Khunger, A., Wahl, R. L., & Balch, C. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-05070-2_29 · Cited by 4
Passive and Active Targeting for Solid Tumors
More, M. P., Deshmukh, P. K., Patil, P. O., Nangare, S., Tade, R. S., Patil, A., Pandey, A. P., Mutalik, S., Patil, P. B., Khan, Z. G., et al. (2022) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-031-14848-4_5 · Cited by 4
Kurniati, N. F., Sukandar, E. Y., Pardilah, R., Suliska, N., & Ayuningtyas, D. K. (2018) · JURNAL ILMU KEFARMASIAN INDONESIA · doi:10.35814/jifi.v16i1.434 · Cited by 4
Sisin, N. N. T., Razak, K. A., Mat, N. F. C., Abdullah, R., Rashid, R. A., Zainudin, N. H. M., Anuar, M. A. K., Jamil, A., Geso, M., & Rahman, W. N. (2022) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2022.01.017 · Cited by 4
Gilloteaux, J., Jamison, J. M., Arnold, D., & Summers, J. L. (2018) · Wiley eBooks · doi:10.1002/9781119432463.ch28 · Cited by 4
Li, C.-Y., Ding, D., Guo, Y., Fu, Y., Shen, Y., Fu, J., Zhang, C.-X., & Han, F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06840-5 · Cited by 3
Turning Tumor Acidosis into a Therapeutic Advantage with Nanomedicine
Ren, K., Pang, L., Lv, S., Yi, R., Tian, L., Ni, N., Sun, X. J., Cheng, J., Zhang, X., & Xu, X. (2025) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00021 · Cited by 3
Gilloteaux, J., Jamison, J. M., Summers, J. L., & Taper, H. S. (2024) · Ultrastructural Pathology · doi:10.1080/01913123.2024.2379300 · Cited by 3
Balancing the cellular budget: Lessons in metabolism from microbes to cancer
Vibishan, B., Jolly, M. K., & Goyal, A. (2025) · Biosystems · doi:10.1016/j.biosystems.2025.105571 · Cited by 3
Molecular and therapeutic bases of cancer
Fajardo-Orduña, G. R., & Chamorro-Plata, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819828-5.00002-4 · Cited by 3
Udono, H., & Nishida, M. (2021) · International Immunology · doi:10.1093/intimm/dxab067 · Cited by 3
Chen, G., She, W., Yu, C.-C., Rouzi, T., Li, X., Ma, L., Zhang, N., Jiang, H., Liu, X., Wu, J., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04333-2 · Cited by 3
Chen, H., Maxwell, C. A., & Connell, M. (2014) · Cancer metastasis · doi:10.1007/978-3-319-12136-9_2 · Cited by 3
Icard, P., Zhang, X., Varin, E., Allouche, S., Coquerel, A., Paciencia, M., Joyeux, L., Gauduchon, P., Lincet, H., & Poulai, L. (2012) · InTech eBooks · doi:10.5772/30958 · Cited by 2
Challenges in Pharmacotherapy of Neoplastic Diseases – The Search for Addictions
Féron, O. (2010) · Frontiers in Pharmacology · doi:10.3389/fphar.2010.00120 · Cited by 3
Le métabolisme de la cellule tumorale : l’effet Warburg
Zemmour, D., & Vignot, S. (2013) · ONCOLOGIE · doi:10.1007/s10269-013-2318-2 · Cited by 10
Idowu, M. A. (2011) · Biotechnology & Biotechnological Equipment · doi:10.5504/bbeq.2011.0107 · Cited by 3
Regulation of Host Chromatin by Bacterial Metabolites
Mani, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802389-1.00023-x · Cited by 3
Metabolic Reprogramming in Cancer
Prusty, D., & Manna, S. K. (2022) · Wiley eBooks · doi:10.1002/9781119851042.ch25 · Cited by 3
Fang, G. H., Zhou, X., Ran, C. L., Jin, C. X., Bu, S., Chen, Y., Gong, Y., Hu, Z., Song, F. B., Luo, J., et al. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.178921 · Cited by 2
Salivary metabolite-based prediction of radiotherapy-induced oral mucositis and candidiasis
Ramsay, S., Hyvärinen, E., Mikkonen, J. J. W., González‐Arriagada, W. A., Salo, T. A., Lopes, M. A., Kashyap, B., & Kullaa, A. M. (2025) · Clinical Oral Investigations · doi:10.1007/s00784-025-06690-x · Cited by 2
Kumar, P., Rastogi, S., Arora, M. K., & Singh, L. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156342 · Cited by 2
New horizons: disrupted brain energy metabolism as a driver of delirium
Sabharwal, M., Boyd, G., & Cunningham, C. M. (2026) · Age and Ageing · doi:10.1093/ageing/afag024 · Cited by 2
Metabolic Reprogramming of Urothelial Carcinoma—A Theragnostic Target for Betulinic Acid
Ganguly, A., Healy, K. M., Daugherty, S. L., Haldar, A., Kimura, S., Banerjee, R., Beckel, J. M., & Tyagi, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125598 · Cited by 2
The role of fibroblast growth factors in cell and cancer metabolism
Price, J., & Francavilla, C. (2025) · FEBS Letters · doi:10.1002/1873-3468.70199 · Cited by 3
Cancer Biology: Some Causes for a Variety of Different Diseases
Okal, A., Reaz, S., & Lim, C. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7876-8_5 · Cited by 2
Impaired mitochondrial bioenergetics and signaling pathways
Bhatti, J. S., Pahwa, P., Reddy, P. H., & Bhatti, G. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00002-4 · Cited by 2
(2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1781-5.00005-2 · Cited by 2
Molecular Imaging and Radiobiology
Shaikh, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-9535-3_22 · Cited by 2
Mitochondrial Mutations in Cancer Progression: Causative, Bystanders, or Modifiers of Tumorigenesis?
Kurelac, I., Vidone, M., Girolimetti, G., Calabrese, C., & Gasparre, G. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_10 · Cited by 2
Uddin, M., Kawami, M., Yumoto, R., & Takano, M. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01802-3 · Cited by 2
Higareda‐Almaraz, J. C., Valtierra-Gutiérrez, I. A., Hernández‐Ortíz, M., Contreras, S., Hernandez, E., & Encarnación‐Guevara, S. (2013) · PLoS ONE · doi:10.1371/annotation/b212d5e5-7c4b-48c1-80ff-ba0d4ce87cfc · Cited by 2
Designing metabolic target-specific inhibitors for cancer therapy
Singh, T., Kharat, A. S., Rathi, B., & Kumar, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99879-6.00011-0 · Cited by 1
Hypoxia in Head and Neck Cancer: Current Relevance
Féron, O. (2025) · Springer eBooks · doi:10.1007/978-3-031-84539-0_13 · Cited by 2
Hamed, M. A., Ekundina, V. O., & Enye, L. A. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115727 · Cited by 1
Shao, D., Wang, J., Zou, K., Chen, Y., Zhang, P., & Song, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-22477-2 · Cited by 1
Lei, C., Song, H., Song, H., Du, J., Zhu, T., Tian, J., & Li, S. (2025) · Fish Physiology and Biochemistry · doi:10.1007/s10695-025-01601-z · Cited by 1
Hyperpolarized MRI theranostics in cancer
Yamashita, K., Zhao, Z., Saito, K., & Takakusagi, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1693853 · Cited by 1
Hypoxia Affects Stem Cell Fate in Patient-Derived Ileum Enteroids in a HIF-1α-Dependent Manner
Uckeley, Z. M., Kee, C., Ramirez, C., Karaluz, V., Sharma, A. K., Polanco, J., Martinez, F. D. O., Mederos, C., Jacobs, S. O., Groose, I. J., et al. (2025) · Cells · doi:10.3390/cells15010031 · Cited by 2
Li, X., Guo, W., Xie, Y., Li, R., Li, W., Wang, H., Du, R., Jiang, H., Liu, Y., & Liu, Z. (2026) · Current Molecular Pharmacology · doi:10.1016/j.cmp.2026.04.002 · Cited by 1
Toluquinol, A Marine Fungus Metabolite, Inhibits Some of the Hallmarks of Cancer
García‐Caballero, M., Medina, M. Á., & Quesada, A. R. (2014) · Springer eBooks · doi:10.1007/978-3-319-07145-9_14 · Cited by 1
New Cancer Paradigm and New Treatment: The Example of METABLOC
Schwartz, L. H., Summa, M. G., Steyaert, J. M., Guais, A., & Baronzio, G. F. (2013) · Conference Papers in Medicine · doi:10.1155/2013/827686 · Cited by 1
Cancer generated lactic acid: Novel therapeutic approach
Gupta, K. (2016) · International Journal of Applied and Basic Medical Research · doi:10.4103/2229-516x.173976 · Cited by 1
HNSCC Biomarkers Derived from Key Processes of Cancerogenesis
Raudenská, M., Gumulec, J., Fribley, A. M., & Masařík, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27647-2_7 · Cited by 1
Effects of Hypoxia and HIF-1 on Glutamine Metabolism
刘, 梦. (2021) · Bioprocess · doi:10.12677/bp.2021.111001 · Cited by 1
Tran, A., Moon, J. T., Shaikh, J., & Nezami, N. (2022) · Minimally Invasive Therapy & Allied Technologies · doi:10.1080/13645706.2022.2040535 · Cited by 1
Diagnosis of Stage IV Melanoma
Tarhini, A. A., Agarwala, S. S., Khunger, A., Wahl, R. L., & Balch, C. M. (2019) · Springer eBooks · doi:10.1007/978-3-319-46029-1_29-1 · Cited by 1
Are carcinogens electron acceptors? A novel hypothesis
Rao, U. V., Arakeri, G., Subash, A., Venkatesh, M., & Brennan, P. A. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110235 · Cited by 1
Intestinal Hydrogen Gas as Co-Creator of both Human Immunity and Aura
Pivovarenko, Y. (2022) · Journal of Clinical Case Reports and Studies · doi:10.31579/2690-8808/146 · Cited by 1
Harrison, H. G. (2016) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
Peptide-based drugs to inhibit LDH5, a potential target for cancer therapy
Nadal‐Bufí, F. (2022) · Queensland University of Technology · doi:10.5204/thesis.eprints.232526 · Cited by 1
Estudio de los mecanismos moleculares y celulares de la función protectora de la Apolipoproteína D
Bajo‐Grañeras, R. (2012) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/1714
Case Study: Systems Biology of Chemotherapy Resistance in Hypoxic Cancer
Armitage, E. G., Kotze, H. L., & Williams, K. J. (2014) · SpringerBriefs in systems biology · doi:10.1007/978-1-4939-0615-4_6
Metadata
- Authors
- Feron, O.
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 92
- Issue
- 3
- Pages
- 329-333
- ISSN
- 0167-8140 (ISSN-L)
- OpenAlex
- W2002922559
- Cited by
- 559
- References
- 38
- Citations by year
- 2026: 13 · 2025: 37 · 2024: 25 · 2023: 28 · 2022: 40 · 2021: 50 · 2020: 44 · 2019: 37 · 2018: 32 · 2017: 30 · 2016: 38 · 2015: 32 · 2014: 35 · 2013: 42 · 2012: 17
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiotherapy and Oncology (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (submittedVersion)
- Funders
- Fonds De La Recherche Scientifique - FNRS
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- Warburg effect, cancer metabolism, lactate, pyruvate, glycolysis, glutaminolysis, NAD+ regeneration, NADPH, pentose phosphate pathway, MCT1, LDHA, pyruvate dehydrogenase, hypoxia, oxidative metabolism, TCA cycle, alpha-ketoglutarate, glucose deprivation, combined radiotherapy
- MeSH terms
- Cell Survival, Energy Metabolism, Glycolysis, Humans, NAD, NADP, Neoplasms, Oxidation-Reduction, Radiation Tolerance, Sensitivity and Specificity, Cell Hypoxia, Cell Death, Pyruvic Acid, Lactic Acid, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review